ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2069

Gout Is More Frequent in Sickle Cell Disease Than the General Population

Richard Akintayo1, Olufemi Adelowo2, Adindu Chijioke1, Timothy Olanrewaju1, Kehinde Olufemi-Aworinde3 and Foluke Akintayo4, 1Internal Medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria, 2Arthrimed Specialist Clinic:The Arthritis Centre, Lagos, Nigeria, 3Haematology, Bowen University Teaching Hospital, Ogbomosho, Nigeria, 4Family Medicine, Ladoke Akintola University of Technology Teaching Hospital, Ogbomosho, Nigeria

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Arthritis, gout and hyperuricemia

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Metabolic and Crystal Arthropathies Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Despite the well known risk of hyperuricaemia in Sickle Cell Disease (SCD), it has not been determined if these patients are more prone to gout than the general populace. We studied the frequencies of gout between patients with SCD and controls with haemoglobin AA genotype and determined the factors associated with gout in SCD.

Methods: A prospective study of 104 patients with haemoglobin SS or SC and 104 age and sex-matched control participants with haemoglobin AA was conducted at the University of Ilorin Teaching Hospital, Nigeria. Clinical and demographic information were obtained from each participant and 10 ml of venous blood was taken for determination of haemoglobin genotype, serum uric acid and creatinine. Joint aspiration was done in all individuals presenting with articular pain and swelling. This sample was examined by polarized microscopy for monosodium urate crystals.

Results: The mean age of the patients was 27.4±8.3 years. Eight (7.7%) of the patients had genotype SC while the remaining 96 (92.3%) had SS. Hyperuricaemia was found in 28 (26.9%) and 2 (1.9%) individuals with SCD and controls respectively (p0.001). Six (5.8%) cases of gout were found among the SCD patients and none among the controls (p=0.029). None of the gouty individuals had ever been diagnosed with gout before and they all had serum uric acid in the hyperuricaemic range. Four (66.7%) of them were males giving a male-female ratio of 2:1. The pattern of articular involvement was monoarticular in 2 (33.3%), oligoarticular in 3 (50%) and polyarticular in 1 (16.7%). The knee was the most frequently affected joint seen in 4 patients. Five (66.7%) individuals reported having had painful and swollen joints on more than two occasions in the past while only one (16.7%) reported a single previous episode. One (16.7%) patient had subcutaneous tophi. Factors associated with gout in SCD were age, hyperuricaemia, more than two SCD crises in the past year and more than two hospital admissions in the past year (p 0.05 in each case).

Conclusion: Gout is more frequent in SCD than in individuals with HbAA genotype and many episodes of gouty attacks may have been mistaken for vaso-occlusive crises thereby delaying correct diagnosis and leading to mounting morbidities.

Characteristics of the patients with gout

Age (years)

Sex

Genotype

SUA (µmol/L)

BMI (Kg/m2)

Joints involved

Presence of tophi

1

52

F

SS

435

23.31

Ankles

Yes

2

41

M

SS

480

17.51

Lt. knee, Rt. MTP1

No

3

37

M

SS

702

19.84

Rt. ankle

No

4

41

M

SS

510

20.20

Knees, Rt elbow, ankles

No

5

44

F

SS

460

18.87

Rt. Ankle, Lt. knee, Lt. MTP1

No

6

35

M

SC

440

24.06

Lt. Knee

No

SUA=Serum Uric Acid; BMI=Body Mass Index; Lt.=Left; Rt.=Right; MTP1=1st metatarsophalangeal joints

Factors associated with gout among patients with SCD

Patients with gout

N=6 (%)

Patients without gout N=98 (%)

P-value

Genotype

SS

5 (83.3)

91 (92.8)

0.389

SC

1 (16.7)

7 (7.1)

Age

18-27

0 (0.0)

59 (60.2)

0.001

28- 37

2 (33.3)

32 (32.7)

38-47

3 (50.0)

6 (6.1)

48-57

1 (16.7)

1 (1.0)

Sex

Male

4 (66.7)

52 (53.1)

0.684

BMI

Underweight

1 (16.7)

28 (28.6)

0.753

Normal weight

5 (83.3)

68 (69.4)

Overweight

0 (0.0)

2 (2.0)

Hyperuricaemia

6 (100.0)

22 (22.5)

0.001

Seafood consumption

6 (100.0)

92 (93.9)

0.532

Animal innards consumption

6 (100.0)

91 (92.9)

0.498

Sweetened beverage consumption

4 (66.7)

89 (90.8)

0.121

Alcohol Consumption

0 (0.0)

5 (5.1)

0.738

Smoking

0 (0.0)

2 (2.0)

0.724

Frequency of SCD Crises

More than 2

5 (83.3)

18 (18.7)

0.002

Two or fewer

1 (16.7)

80 (81.6)

Frequency of Admissions

More than 2

5 (83.3)

18 (18.7)

0.002

Two or fewer

1 (16.7)

80 (81.6)

Routine folic acid use

6 (6.1)

93 (93.9)

0.738

SCD= Sickle Cell Disease; BMI= Body Mass Index


Disclosure: R. Akintayo, None; O. Adelowo, None; A. Chijioke, None; T. Olanrewaju, None; K. Olufemi-Aworinde, None; F. Akintayo, None.

To cite this abstract in AMA style:

Akintayo R, Adelowo O, Chijioke A, Olanrewaju T, Olufemi-Aworinde K, Akintayo F. Gout Is More Frequent in Sickle Cell Disease Than the General Population [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/gout-is-more-frequent-in-sickle-cell-disease-than-the-general-population/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gout-is-more-frequent-in-sickle-cell-disease-than-the-general-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology